Literature DB >> 1385066

Mechanisms and consequences of portal hypertension.

P M MacMathuna1.   

Abstract

Portal hypertension is characterised by alterations in the splanchnic and systemic circulation resulting in the development of portosystemic collateral channels, the most important of which are found in the lower oesophagus and stomach. The major clinical complication of gastro-oesophageal varices is bleeding and over the last decade there has been considerable interest in the pharmacological management of this complication. The factors currently implicated in the development of gastro-oesophageal varices in patients with cirrhosis include a) increased portal vascular resistance, b) splanchnic and systemic vasodilatation and c) changes in the lower oesophageal venous anatomy [palisade and perforating venous zones]. In a patient with gastrointestinal bleeding, endoscopic examination of the upper gastrointestinal tract will confirm the diagnosis of portal hypertension by confirming the presence of gastro-oesophageal varices. Cirrhosis is the most common aetiological factor for gastro-oesophageal varices, but imaging techniques, including Doppler ultrasound, computerised tomography and venous phase angiography, may be required to exclude extrahepatic portal venous obstruction from the differential diagnosis. Although the pathogenesis of variceal rupture remains unclear, several risk factors for variceal haemorrhage have been identified, including a) increased size, b) high intravariceal-portal pressure, c) increased varix wall tension characterised by the presence of red spots observed at endoscopy (particularly in large varices since wall tension is related to variceal size), and d) poor liver function. Although oesophagitis may be observed at endoscopy, an erosive mechanism is no longer considered to be of pathogenic significance. A high portal pressure in the immediate postbleeding period is now recognised as predictive of rebleeding. Periodic elevations in intravariceal pressure, associated with the release of enhanced endogenous vasoactive compounds, or beta-adrenergic-mediated stress-related increases in portal pressure, may contribute to the rupture mechanism. Consequently, portal hypertension is now being more widely considered as a multiorgan disorder associated with changes in blood flow within both systemic and splanchnic vascular beds. This article reviews the factors currently implicated in the development of portal hypertension and the approach to diagnosis. The pathogenesis of variceal bleeding will also be considered.

Entities:  

Mesh:

Year:  1992        PMID: 1385066     DOI: 10.2165/00003495-199200442-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  95 in total

1.  Circulatory changes in chronic liver disease.

Authors:  J F MURRAY; A M DAWSON; S SHERLOCK
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

2.  Non-invasive diagnosis of portal vein occlusion by radionuclide angiography.

Authors:  P MacMathuna; M K O'Connor; D G Weir; P W Keeling
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

3.  Hepatic arterial and portal venous components of liver blood flow: a dynamic scintigraphic study.

Authors:  M K O'Connor; P MacMathuna; P W Keeling
Journal:  J Nucl Med       Date:  1988-04       Impact factor: 10.057

4.  Effect of plasma-volume expansion on portal hypertension.

Authors:  J L Boyer; C Chatterjee; F L Iber; A K Basu
Journal:  N Engl J Med       Date:  1966-10-06       Impact factor: 91.245

5.  Budd-Chiari syndrome in women taking oral contraceptives.

Authors:  A M Hoyumpa; L Schiff; E L Helfman
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

6.  Vascular reactivity in experimental portal hypertension.

Authors:  A Bomzon; L M Blendis
Journal:  Am J Physiol       Date:  1987-02

Review 7.  Intestinal blood flow.

Authors:  D N Granger; P D Richardson; P R Kvietys; N A Mortillaro
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

8.  Grey-scale ultrasonography of portal vein.

Authors:  L J Webb; L A Berger; S Sherlock
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

9.  An epidemic of veno-occlusive disease of liver in central India.

Authors:  B N Tandon; H D Tandon; R K Tandon; M Narndranathan; Y K Joshi
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

10.  Comparison of pulsed Doppler sonography and angiography in patients with portal hypertension.

Authors:  R C Nelson; K E Lovett; J L Chezmar; J H Moyers; W E Torres; F B Murphy; M E Bernardino
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

View more
  3 in total

1.  48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.

Authors:  D Ludwig; S Schädel; A Brüning; B Schiefer; E F Stange
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Acquired portosystemic collaterals: anatomy and imaging.

Authors:  Andréa Farias de Melo Leite; Américo Mota; Francisco Abaeté Chagas-Neto; Sara Reis Teixeira; Jorge Elias Junior; Valdair Francisco Muglia
Journal:  Radiol Bras       Date:  2016 Jul-Aug

Review 3.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.